. "Appendix O: Prospects for Immunizing Against Rotavirus." New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States. Washington, DC: The National Academies Press, 1985.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Vaccine Development Establishing Priorities, Volume I: Diseases of Importance in the United States
bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet II:807–811.
Vesikari, T., E.Isolauri, E.O’Hondt, A.Delem, F.E.Andre, and G. Zissis. 1984. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet I:977–981.
Wyatt, R.G., C.A.Mebus, R.H.Yolken, A.R.Kalica, H.D.James, A.Z. Kapikian, and R.M.Chanock. 1979. Rotaviral immunity in gnotobiotic calves: heterologous resistance to human virus induced by bovine virus. Science 203 (4380):548–550.
Wyatt, R.G., K.W.Thiel, L.J.Saif, A.R.Kalica, H.B.Greenberg, A.Z. Kapikian, and R.M.Chanock. 1980. Human rotavirus type 2: cultivation in vitro. Science 207(4427):189–191.
Wyatt, R.G., H.B.Greenberg, W.D.James, A.L.Pittman, A.R.Kalica, J. Flores, R.M.Chanock, and A.Z.Kapikian. 1982. Definition of human rotavirus serotypes by plaque reduction assay. Infect. Immun. 37(1):110–115.
Zissis, G., J.P.Lambert, P.Marbehant, D.Marissens, M.Lobmann, P. Charlier, A.Delem, and N.Zygraich. 1983. Protection studies in colostrum-deprived piglets of a bovine rotavirus vaccine candidate using human rotavirus strains for challenge. J. Infect. Dis. 148(6):1061–1068.
